Navigation Links
The Leukemia & Lymphoma Society, Valor Biotherapeutics and ImmunGene Create Partnership to Advance Novel Therapy for Non-Hodgkin Lymphoma Patients
Date:5/22/2013

ds lifesaving blood cancer research around the world and provides free information and support services. LLS has played a role in funding nearly every currently available treatment for blood cancer patients today.  Founded in 1949 and headquartered in White Plains, NY, LLS has chapters throughout the United States and Canada. To learn more, visit www.LLS.org. Patients and caregivers should  contact the Information Resource Center at (800) 955-4572, Monday through Friday, 9 a.m. to 6 p.m. ET. 

About Valor Biotherapeutics, LLC
Valor Biotherapeutics is a joint venture between ImmunGene, Inc. and Caliber Biotherapeutics, LLC focused on the clinical development and commercialization of the next generation of monoclonal antibody-based therapeutics to treat cancer.

About ImmunGene Inc.
ImmunGene is a privately held biotechnology company focused on the development of monoclonal antibody-based therapies for the treatment of blood cancers and solid tumors.  ImmunGene has several programs at various stages of the development.  In addition, the company has developed proprietary antibody-cytokine fusion technology comprised of highly potent cytokines by genetically engineered with monoclonal antibodies.  ImmunGene has an exclusive license on the antibody-cytokine fusion protein technology developed by Professor Sherie Morrison at UCLA.  A part of the IGN002 preclinical work has been done as a part of  collaborative research with Dr. John Timmerman 's laboratory.  Antibody-fusion proteins are designed to be inactive at therapeutic doses in the bloodstream while highly potent in targeting and killing cancer cells.  This approach is likely to spare healthy cells and thus has the potential to reduce known t
'/>"/>

SOURCE The Leukemia & Lymphoma Society
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Leading Leukemia Experts: High Leukemia Treatment Costs May Be Harming Patients
2. Tosedostat OPAL Study in Acute Myeloid Leukemia Published in Lancet Oncology
3. Launch Of Premium-priced, Novel Targeted Therapies Will Drive Growth In The Acute Leukemia Markets Beginning In 2015
4. The Leukemia & Lymphoma Society and Avella Specialty Pharmacy to Present Free Event on Oral Chemotherapy Drugs
5. Ambit and Astellas Announce Presentation of Results from Phase 2 ACE Study of Quizartinib in Patients with Relapsed or Refractory Acute Myeloid Leukemia (AML) at the 54th Annual Meeting of the American Society of Hematology
6. Burlington Coat Factory Completes Another Record Year of Supporting The Leukemia & Lymphoma Society in its Quest to Beat Cancer
7. Ambit Biosciences Completes $50 Million Financing to Advance Lead Drug Candidate in Acute Myeloid Leukemia
8. Constellation Pharmaceuticals and The Leukemia & Lymphoma Society Partner to Develop Novel BET Inhibitor for the Treatment of Hematologic Malignancies
9. Actinium Pharmaceuticals Commences Screening for the Second Cohort of Patients in the Companys Ongoing Phase I/II Trial in Acute Myeloid Leukemia
10. Actinium Pharmaceuticals Announces The Addition of The Fred Hutchinson Cancer Research Center To Actiniums Multicenter Clinical Trial For Patients With Acute Myeloid Leukemia
11. Trovagene, Inc., Announces Issuance of U.S. Patent for NPM Mutants to Diagnose and Monitor Acute Myeloid Leukemia
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/23/2015)... , Jan. 23, 2015 Cord Blood America, Inc. ( ... or the "Company")  filed a Preliminary Proxy Statement, Schedule 14A, ... today, and provides an update for shareholders detailing why a ... requested. Dear Shareholders, As we reflect ...
(Date:1/23/2015)... 23, 2015  CytoSorbents Corporation (NASDAQ CM: CTSO), a ... cytokine adsorber to reduce deadly inflammation in critically-ill ... $385,642, net of transaction costs, in non-dilutive funding ... Tax Certificate Transfer Program sponsored by the New ...
(Date:1/23/2015)... Ala. , Jan. 23, 2015 Gem Pharmaceuticals ... patients have been enrolled into the Company,s Phase 2 ... and safety of Gem,s lead compound, GPX-150 (an investigational ... advanced or metastatic disease. Logo - ...
Breaking Medicine Technology:Cord Blood America Announces Preliminary Proxy Filing and Details Why a "YES" Vote to Increase Authorized Shares Is Requested 2Cord Blood America Announces Preliminary Proxy Filing and Details Why a "YES" Vote to Increase Authorized Shares Is Requested 3Cord Blood America Announces Preliminary Proxy Filing and Details Why a "YES" Vote to Increase Authorized Shares Is Requested 4CytoSorbents Receives $385,000 in Non-Dilutive Funding from the New Jersey Technology Business Tax Certificate Transfer Program 2CytoSorbents Receives $385,000 in Non-Dilutive Funding from the New Jersey Technology Business Tax Certificate Transfer Program 3Gem Pharmaceuticals Announces Enrollment of Initial Patients in its Phase 2 Clinical Trial to Assess the Efficacy and Safety of GPX-150 in Sarcoma Patients 2
... , , ... 2009 Eiger BioPharmaceuticals, Inc., a biotechnology company developing antiviral therapies, announced ... trial in patients chronically infected with the hepatitis C virus (HCV). The ... antiviral effect of clemizole monotherapy in the absence of interferon. ...
... , , LYON, France ... the vaccines division of the sanofi-aventis Group (EURONEXT: SAN and ... submitted to the U.S. Food and Drug Administration (FDA) a ... vaccine. Responding to recent recommendations by the FDA, the company,s ...
Cached Medicine Technology:Eiger BioPharmaceuticals Announces Initiation of CLEAN-1 HCV Phase 1b Trial 2Eiger BioPharmaceuticals Announces Initiation of CLEAN-1 HCV Phase 1b Trial 3Sanofi Pasteur Submits Supplemental Application for A(H1N1) Pandemic Vaccine to U.S. FDA 2Sanofi Pasteur Submits Supplemental Application for A(H1N1) Pandemic Vaccine to U.S. FDA 3
(Date:1/22/2015)... The City of West Hollywood hosted a news conference on ... anniversary of the Supreme Court decision Roe v. Wade, which legalized ... the Roe vs. Wade decision and the fight to protect a ... City of West Hollywood Councilmember Abbe Land. “We need to continue ...
(Date:1/22/2015)... Padre Murphy's and Owner Tom Boyle in Glendale, ... Health Alliance (PPHA). The PPHA's passion for others' well-being ... NFL greats, treated for obstructive sleep apnea (OSA) has propelled ... cause in the valley. The most recent plans for an ...
(Date:1/22/2015)... 23, 2015 Angelweddingdress is a famous wedding ... its customers to follow it on Facebook, Twitter, and Pinterest. ... Day gift. Angelweddingdress draws a lottery every week. , Moreover, ... Feb. 28, 2015. Click Angelweddingdress homepage for more ...
(Date:1/22/2015)... New York, New York (PRWEB) January 22, 2015 ... ( http://www.vaginalmeshlawsuit2015.com/ ) in the U.S. District Court, Southern District ... against C.R. Bard, Inc. in that proceeding’s first bellwether trial. ... defense request for a new trial after finding that C.R. ...
(Date:1/22/2015)... New York, New York (PRWEB) January 22, 2015 ... filed after Fresenius Medical Care recalled its GranuFlo ... the federal multidistrict litigation underway in U.S. District Court, ... an Order dated January 20th, the Court has remanded ...
Breaking Medicine News(10 mins):Health News:Padre Murphy's Holds NFL Retired Players Association Party Star Studded Event With Bud Light and Pro Player Health Alliance Sponsoring 2Health News:Padre Murphy's Holds NFL Retired Players Association Party Star Studded Event With Bud Light and Pro Player Health Alliance Sponsoring 3Health News:Angelweddingdress Invites Its Customers To Follow It On Facebook, Twitter, And Pinterest 2Health News:Court Upholds $2 Million Vaginal Mesh Lawsuit Verdict Levied Against C.R. Bard in First Federal Bellwether Trial, Bernstein Liebhard LLP Reports 2Health News:Court Upholds $2 Million Vaginal Mesh Lawsuit Verdict Levied Against C.R. Bard in First Federal Bellwether Trial, Bernstein Liebhard LLP Reports 3Health News:Court Upholds $2 Million Vaginal Mesh Lawsuit Verdict Levied Against C.R. Bard in First Federal Bellwether Trial, Bernstein Liebhard LLP Reports 4Health News:Court Overseeing Federal GranuFlo Lawsuits Remands Louisiana Claim Back to State Court, Bernstein Liebhard LLP Reports 2Health News:Court Overseeing Federal GranuFlo Lawsuits Remands Louisiana Claim Back to State Court, Bernstein Liebhard LLP Reports 3Health News:Court Overseeing Federal GranuFlo Lawsuits Remands Louisiana Claim Back to State Court, Bernstein Liebhard LLP Reports 4
... Jude scientist honored , , MEMPHIS, Tenn., June 16 ... in the Pathology Department at St. Jude Children,s Research Hospital, ... Sciences. , , Selected by The Pew Charitable Trusts ... scientists, Mullighan will receive a $240,000 award over four years ...
... , NIXA, Mo., June 16 The National Autism Association ... charge to qualifying couples who have a child with autism. ... divorce within the autism community, the NAA,s Family First Program ... need of marriage counseling. Now the organization is providing tools ...
... -- Duke University engineers have taken a first ... by combining chemotherapy with heat administered from the end ... it should be technically possible to treat brain tumors ... of surgery, systemic chemotherapy or radiation. The bioengineers ...
... and the Association of Medicine and the Person are collaborating ... . The peer-reviewed, international journal is aimed at medical ... field of ethics and quality of life. The first ... The Journal of Medicine and the Person ...
... of organizations representing healthcare stakeholders throughout Greater Boston ... Foundation (RWJF) to participate in a planning grant ... Quality (AF4Q) initiative. AF4Q is the Foundation,s signature ... in targeted communities, reduce racial and ethnic disparities, ...
... ... ... , , ,Who: ,Dr. Jeffrey Sturchio, Chairman, Corporate Council on Africa, ... Office of the U.S. Global AIDS Coordinator, U.S. Department of State ,Dr. Kate Tulenko, ...
Cached Medicine News:Health News:St. Jude Scientist Named Pew Scholar 2Health News:St. Jude Scientist Named Pew Scholar 3Health News:National Autism Association's Family First Program Now Providing Free Tools to Help Combat Autism Divorce Rates 2Health News:Potential for noninvasive brain tumor treatment 2Health News:Springer to publish Journal of Medicine and the Person 2Health News:Greater Boston unites to transform health care 2Health News:Building Healthcare Leadership in Africa: A Call to Action 2
Angulated, blunt and pointed tips....
Bipolar hand activated forceps....
Angled, pointed, with attached cable for Valleylab and other brands generators....
Angulated, blunt tips....
Medicine Products: